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Abstract
Background: RNA interference (RNAi) is an effective and important tool used to study gene function. For large-scale
screens, RNAi is used to systematically down-regulate genes of interest and analyze their roles in a biological process.
However, RNAi is associated with off-target effects (OTEs), including microRNA (miRNA)-like OTEs. The contribution
of reagent-specific OTEs to RNAi screen data sets can be significant. In addition, the post-screen validation process
is time and labor intensive. Thus, the availability of robust approaches to identify candidate off-targeted transcripts
would be beneficial.
Results: Significant efforts have been made to eliminate false positive results attributable to sequence-specific OTEs
associated with RNAi. These approaches have included improved algorithms for RNAi reagent design, incorporation of
chemical modifications into siRNAs, and the use of various bioinformatics strategies to identify possible OTEs in screen
results. Genome-wide Enrichment of Seed Sequence matches (GESS) was developed to identify potential
off-targeted transcripts in large-scale screen data by seed-region analysis. Here, we introduce a user-friendly web
application that provides researchers a relatively quick and easy way to perform GESS analysis on data from human or
mouse cell-based screens using short interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs), as well as for Drosophila
screens using shRNAs. Online GESS relies on up-to-date transcript sequence annotations for human and mouse genes
extracted from NCBI Reference Sequence (RefSeq) and Drosophila genes from FlyBase. The tool also accommodates
analysis with user-provided reference sequence files.
Conclusion: Online GESS provides a straightforward user interface for genome-wide seed region analysis for
human, mouse and Drosophila RNAi screen data. With the tool, users can either use a built-in database or provide
a database of transcripts for analysis. This makes it possible to analyze RNAi data from any organism for which the user
can provide transcript sequences.
Keywords: RNAi, Off-target effects, Data analysis, Seed region, miRNA, siRNA, shRNA, High-throughput screening
Background
RNA interference (RNAi) is a post-transcriptional gene
regulatory mechanism [1] that has been widely used for
functional genomics studies both in cell lines and organ-
isms. The synthetic duplexes referred to as small inter-
fering RNAs (siRNAs) or short hairpin RNAs (shRNAs)
used for RNAi partner with the RNA Induced Silencing
Complex (RISC) to target messenger RNAs for degrad-
ation in a sequence-specific manner [2,3]. It has been well
established that synthetic duplexes have both on-target
activities (reducing expression of intended gene) as well as
off-target activities (leading to reduced expression of
unintended genes) [4]. A significant fraction of false-
positives from RNAi screens is due to off-target effects
(OTEs) [5,6]. Many efforts have been made to reduce
the number of false positive results due to sequence-
specific OTEs, including improved algorithms for RNAi
reagent design and incorporation of chemical modifications
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bioinformatics strategies to identify possible OTEs in
screening results.
OTEs have been linked to the mechanism of action of
miRNAs, in which a short sequence of bases 2–8 on the
5′ end of a strand of the RNAi duplex (usually the anti-
sense strand), also called the ‘seed region’, is complemen-
tary to the 3′ untranslated regions (UTRs) of multiple
mRNAs, causing degradation of their associated tran-
scripts [8,9]. To improve the interpretation of RNAi
datasets and to help minimize follow-up experimental
efforts, it is important to identify transcripts that are
likely to have scored as a result of seed sequence-based
targeting. A number of off-target analysis algorithms
have been developed and made available to the scientific
community. For example, the Haystack algorithm ana-
lyzes RNAi off-target effects based on a predictive model
trained with published datasets [10]. The model takes
into account four types of seed matches and the length
of 3’ UTR regions. It requires seed sequence diversity
across the dataset and is optimized for large RNAi data-
sets of sufficient scale with normally distributed scores.
Genome-wide Enrichment of Seed Sequence matches
(GESS) is another bioinformatics method developed for
OTE analysis of RNAi screen datasets [11]. It identifies
candidate off-targeted transcripts by investigating the as-
sociation between matches of the seed regions of RNAi
reagents in 3’UTRs with phenotypes observed in large-
scale screens. In GESS, RNAi reagents are grouped into
two categories: siRNA/shRNAs that score in a screen as
“with phenotype” or “active”, and reagents considered
“without phenotype” or “inactive”. The algorithm calcu-
lates a seed match frequency (SMF) for active and inactive
siRNAs/shRNAs for each tested sequence (transcript of a
target gene). It is expected that transcripts (and in particu-
lar, 3’UTR regions) that are significantly over-represented
for seed region matches among active RNAi reagents are
more likely to be off-targets. The GESS algorithm has
been used successfully to identify off-targeted transcripts
in several medium- to large-scale datasets. For example,
MAD2 was identified as an off-targeted transcript in a
spindle assembly checkpoint components screen and
TGFβ-R2 in a screen for novel components of the TGFβ
pathway [11]. GESS was also used in analyzing data
from a screen for genes required for homologous
recombination and predicted RAD51 as a candidate
off-targeted gene; RAD51 OTEs were later confirmed
experimentally to be responsible for the activity of many
siRNAs identified as hits in the primary screen [12].
Previously, MATLAB was used to program and run
the GESS algorithm. Standalone versions of the GESS
MATLAB code were provided for several operating sys-
tems, including Windows, Linux and Mac. Although it
is possible to install and use these stand-alone MATLAB
versions, it is not easy for biologists lacking program-
ming and informatics expertise to implement GESS in
its original form, as the user has to: 1. download and install
the program; 2. provide files for the reference sequences;
and 3. prepare separate files for siRNAs/shRNAs, pheno-
type and reagent sequence information. In addition, the
run time of the program is not optimal for large files. For
example, it can take up to 30 hours to analyze 10,000 siR-
NAs against 27,500 3’UTRs using the standalone MATLAB
version of GESS. Hence, an open, user-friendly online tool
with improved performance would be of interest to the
scientific community.
Implementation
Online GESS was developed as a Java web application.
Twitter Bootstrap 3 front-end framework and jQuery
JavaScript library were used to develop the web pages. At
the back end, Online GESS contains reference sequences
corresponding to 3’UTRs (the region thought to be the
most sensitive to miRNA-off-target effects), 5’UTRs, cod-
ing sequences (CDS) or full-length transcripts (including
non-coding RNAs) in the human, mouse and Drosophila
genomes. The human and mouse sequences are obtained
from the NCBI RefSeq database. Although these se-
quences are derived from GenBank records, RefSeq re-
cords are non-redundant and have gone through additional
levels of validation, annotation, and manual curation. Tran-
script sequences, as well as CDS and UTR annotations, are
retrieved. The Drosophila transcript sequences are obtained
from FlyBase (flybase.org) [13], a comprehensive database
of Drosophila information that is curated by experts to
ensure quality and includes sequences, gene annotation,
mutant alleles and publications. Because curation and
annotation of reference sequences is an ongoing effort,
we have implemented a mechanism for synchronizing
reference sequences with each new RefSeq and FlyBase
release [14,15].
After a user uploads their annotated screen results (i.e.
sequences of active and, if available, inactive RNAi re-
agents) in Excel, comma-separated values or tab-delimited
text format, the online GESS tool extracts the seed
sequences from active and inactive RNAi reagent
sequences, then searches the transcript sequences for
perfect matches. If a set of inactive RNAi reagents is not
provided, the program creates a theoretically inactive
set by replacing the first nucleotide of each seed region
with the complementary nucleotide. The program then
calculates the frequencies of matches among active and
inactive RNAi reagents, and identifies transcripts that
are significantly enriched among active RNAi reagents
using the Fisher exact test and Yates chi-square test. When
t h es a m p l es i z ei ss m a l l ,t h epv a l u ef r o mt h eF i s h e r ’s Exact
Test is selected; otherwise, the p value from the Yates Chi
Square test is used. Transcripts are then ranked based on
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ing multiple hypothesis correction. Three multiple hy-
pothesis correction methods are used in the analysis,
the Bonferroni, Bonferroni step-down and Benjamini &
Hochberg algorithms, listed in order from most to
least stringent correction. Detailed information about
the GESS algorithm and analysis methods can be found
in the original publication [11].
User interface
The online GESS application functions as an interface
for submitting data and setting parameters for GESS
analysis. The output files are sent via e-mail if their size
is equal to or smaller than 15 MB. For larger files, a link
to download resulting files is provided to user by email.
The output files will be available for the user to down-
load for 48 hours.
User input
In order to perform a GESS analysis, the user has to
provide siRNA or shRNA information in one of the re-
quired formats (e.g. tab or comma separated text file or
Excel file). There are two possible layouts for input si/
shRNA files. The first requires the sequences of both ac-
tive and inactive siRNAs/shRNAs, as well as their corre-
sponding phenotype/activity information (see example
file at http://www.flyrnai.org/gess/ActiveAndInactiveSiR-
NAs.txt). The second layout includes only the sequences
of active siRNAs/shRNAs, and phenotype/activity infor-
mation is not needed (all reagents are assumed to be
active; see example file at http://www.flyrnai.org/gess/
ActivesiRNAs.txt). The user then chooses the correct
format for their input file by selecting “Input file con-
tains both active and inactive RNAi reagents” or “Input
file contains only active RNAi reagents”. The user also
needs to indicate if the input sequences represent the
sense (passenger) or anti-sense (guide) strands of the re-
agents. In addition, the user has to indicate the reagent
type, siRNA or shRNA. If shRNA is selected, it is pos-
sible for the user to trim the sequences by one to three
nucleotides respectively since sequences provided by the
source of shRNA library may not reflect the actual
mature siRNA strands that are generated by expected
canonical dicer cleavage.
The next step is to specify a reference database. As de-
scribed above, online GESS has built-in reference data-
bases for the human, mouse and Drosophila genomes.
The user can choose one of the three species and then
specify the transcript region(s) to search against. The
options are 3’UTR (preferred genomic region for GESS
analysis), 5’UTR, CDS, full transcript of protein coding
genes, or full transcript region of all genes including
non-coding RNA. The user can also choose to upload a
custom database file. A custom database file should have
FASTA formatted sequences (see example file at http://
www.flyrnai.org/gess/customDatabase.txt). For a custo-
mized reference database, the program will search for seed
matches along the full length of the sequences provided. If
the user would like to focus the search to a specific sub-
region within a custom reference set, such as 3’UTRs
(thought to be the major site of miRNA activity), the user
is responsible for uploading only the 3’UTR sequences.
The final step prior to submitting data for processing is
to specify any optional parameters. The GESS interface
allows users to specify the length of a seed sequence, the
minimum number of seed matches to be found in the tar-
get sequence, the strand of the RNAi sequence, as well as
a statistical threshold value. Currently, the default settings
are 7 base pair seed sequence (nucleotides 2–8f r o mt h e5 ’
end of antisense sequences provided by user), a minimum
of one seed match using the anti-sense strand of RNAi
only, and a p-value threshold of 0.05 before multiple
hypothesis testing correction. The user has the option to
perform a control test where each seed sequence of both
active and inactive reagents is randomly scrambled. This
provides a sense of strength of outliers that may occur at
random and more confidence that the significant results
are not due to chance. To do this, the user needs to run a
parallel test by making corresponding selection under
“Advanced Options” at the user interface. This will pro-
vide a new set of results and make it possible for users to
compare the results obtained for the experimental and
control test sets. It is important to note that the program
generates only one set of results at a time. Hence, to in-
clude a control test in the overall analysis, the control test
has to be submitted and run separately.
Online GESS pre-processes the input files and detects
mis-formatted records, such as lines missing sequence
information, before the analysis starts. If more than 25%
of the records are mis-formatted, the error type (see help
page at http://www.flyrnai.org/gess/help.jsp) as well as a
few examples will be displayed to the user. This feature
enables the user to identify errors in their files immedi-
ately and fix them. If less than 25% of the records fail
pre-processing, the tool continues the analysis, ignoring
mis-formatted records in the analysis. The user is then in-
formed via email about the number of RNAi reagents that
were ignored in the analysis and their location in the file.
Output files
A GESS analysis generates two output files. The first file
lists the transcripts identified by seed region match to
active RNAi reagents and their enrichment scores. By
default, this file contains results for all tested transcripts.
If the user is not interested in getting the full list, the results
of significant transcripts can be obtained by choosing “Only
Significant Transcripts” under advanced options. When
using a built-in database, each transcript is indicated by its
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gene symbol from NCBI or FlyBase. If a custom data-
base is provided, the comment lines from the FASTA
file are displayed. This first file also reports the num-
ber of active RNAi reagents that have seed matches to
a given sequence, the seed match frequency of active
reagents, and the p-values according to both Fisher’s
Exact and Yates Chi Square tests. The output file also
reports the p-value selected for multiple hypothesis
correction and the adjusted p-values, as calculated
using the Bonferroni, Bonferroni Step-down and Ben-
jamini & Hochberg methods. Finally, the corrected p-
value thresholds, as well as statistical significance sta-
tus of each transcript according to each algorithm, are
reported in this file. The second file contains the tran-
script identifiers and a list of active RNAi reagents that
match to them. This file contains only the transcripts
with p-values≤ 0.05. If the analysis fails during input
file processing, an email notification is sent to the user
(see help page for detailed explanation, http://www.
flyrnai.org/gess/help.jsp).
Run time
The run time of a GESS analysis is dependent upon the
input file sizes but in most cases, the analysis is
complete within a couple of minutes. For example, in
our tests it took two minutes to analyze 10,000 siRNAs
against about 68,450 3’UTRs annotated for human genes
in RefSeq database (vs61).
Testing
We compared Online GESS to the standalone MATLAB
version using supplementary data from a spindle assem-
bly checkpoint screen as provided in the original GESS
publication [11]. The original publication used tran-
scripts from Ensembl as the reference, whereas by
default, Online GESS uses transcripts from RefSeq. To
do a direct comparison, at Online GESS we uploaded a
custom database of 3′UTR sequences from Ensembl as
provided in the original publication [11]. We then ran
Online GESS using the same parameters as those used
in the original publication (a 7mer seed match from
either strand) [11] and obtained the same results. Next,
we ran another Online GESS analysis with the same pa-
rameters using our built-in database of human 3′UTR
sequences (by default, this was the current RefSeq
release, i.e. v61). The results were the same at the gene
level; that is, MAD2 was the only significant outlier.
T h eo n l yd i f f e r e n c e sw eo b s e r v e db e t w e e nr e s u l t s
obtained with the standalone MATLAB version and
Online GESS were at the transcript level (not at the
gene level) and are attributable to differences in the
underlying reference data.
Results and discussion
Using this tool, we analyzed datasets from several publica-
tions (Table 1). For the majority of cell lethality screens,
Online GESS did not identify any potential off-target
genes when the sequences of top hits were analyzed. Cell
lethality is a phenotype that can be triggered by a broad
range of biological pathways and it is possible that the
GESS approach is not sensitive enough to identify poten-
tial off-target genes in these cases. On the other hand, for
screens measuring phenotypes with more defined molecu-
lar mechanisms, such as a spindle assembly checkpoint
components screen and a screen for novel components of
TGFβ pathway, Online GESS identified potential off-
target transcripts (namely, MAD2 in the spindle assembly
checkpoint screen and TGFβ-R2 in the TGFβ pathway
screen). We also analyzed the ionizing radiation (IR) sensi-
tivity screen published by Hurov et al. [16]. The authors
report two datasets for the IR sensitivity phenotype. One
is comprised of 850 shRNAs that scored in the primary
screen; the other comprises 114 shRNAs that were vali-
dated using independent shRNAs. Online GESS did not
find any potential OTEs among validated hits but found
that ZNF480 and SH3BP2, which appear in the primary
hit list, might be off-targeted transcripts. This is consistent
with the idea that GESS can help narrow down a list of
primary hits and prioritize hits for further validation.
In Drosophila,s h o r th a i r p i nR N A sh a v eb e e nu s e df o r
large-scale in vivo screens [26]. We analyzed results from
two screens for embryonic phenotypes associated with
maternally loaded shRNAs [24,25]. We did not find any
potential off-target genes with either dataset, possibly due
to the small size of these studies (1000 or 2300 shRNAs,
respectively). As more transgenic shRNA screens are
done, we anticipate that GESS will prove useful to
detect potential off-targeted transcripts that might be
associated with in vivo Drosophila RNAi screen data.
Conclusions
RNAi is a powerful tool for systematic study of gene func-
tions but results must be analyzed carefully, as screens are
a s s o c i a t e dw i t hf a l s ep o s i t i v ea n df a l s en e g a t i v er e s u l t s .F u r -
ther validation of results, such as screening with multiple
independent RNAi reagents, performing qPCR to verify
correlation between knockdown efficiency and phenotypic
strength, or RNAi-resistant “rescue” experiments, is time
and labor intensive. Detection of potential off-targeted tran-
scripts via automated pre-processing based on our current
knowledge of the sources of off-targets, including miRNA-
like effects, provides one way to focus limited resources on
the most promising candidates. To help support automated
detection of off-targeted transcripts in RNAi data, we have
implemented a web-based application of seed region ana-
lysis for identification of potential off-target transcripts,
based on the GESS algorithm. This tool allows users to run
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mouse or Drosophila datasets directly using built-in refer-
ence sequence database. In addition, screen data can be
analyzed based on a custom reference database, making it
possible to analyze RNAi screen results from any organ-
ism and at any scale.
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Table 1 Datasets tested using the GESS online tool and results




A genetic screen identifies the Triple T complex
required for DNA damage signaling and ATM and ATR
stability [16]




Ionizing radiation resistance 1080 None
An intermittent live cell imaging screen for siRNA
enhancers and suppressors of a kinesin-5 inhibitor [17]




Off-target effects dominate a large-scale RNAi screen for
modulators of the TGF-β pathway and reveal microRNA
regulation of TGFBR2 [18]
siRNA (hs) Genes involved in TGF-β
signaling (Sloan Kettering Inst.
In house library)
409 TGFBR2
Genome-wide siRNA screen identifies SMCX, EP400
and Brd4 as E2-dependent regulators of human
papillomavirus oncogene expression [19]
siRNA (hs) Genes that contribute to the
repression of the HPV LCR.
(Dharmacon library)
511 None
A genome-wide homologous recombination screen
identifies the RNA-binding protein RBMX as a component
o ft h eD N A - d a m a g er e s p o n s e[ 12]








Kinase requirements in human cells: I. Comparing
kinase requirements across various cell types [20]
TRC shRNA (hs) Essential kinases in HeLa
and 293 T cell lines.
110 None
A Lentiviral RNAi Library for Human and Mouse Genes
Applied to an Array Viral High-Content Screen [21]
TRC shRNA (hs) Genes required for mitotic
progression and proliferation
for HT29 cell line
161 None
Highly parallel identification of essential genes in
cancer cells [22]
TRC shRNA (hs) Essential genes for 12 cancer
cell lines
182 None
Systematic investigation of genetic vulnerabilities across
cancer cell lines reveals lineage-specific dependencies
in ovarian cancer [23]
TRC shRNA (hs) Essential genes specifically
for Ovarian cell lines
~1500 (top ~3%) None
Essential genes specifically
for Colon cell lines
~1500 (top ~3%) None
Essential genes specifically
for Pancreas cell lines




~1500 (top ~3%) TACO1
Depleting gene activities in early Drosophila embryos
with the "maternal-Gal4-shRNA" system [24]
shRNA (dm) Abnormal embryonic
phenotypes
79 None
A regulatory network of Drosophila germline stem cell
self-renewal [25]
shRNA (dm) Abnormal embryonic
phenotypes
329 None
Note: The results presented here were obtained using the following parameters: “3’UTR” as genomic region, “antisense/guide” as strand to use, “7” as seed
sequence length. The shRNA libraries from The RNAi Consortium (TRC) were trimmed by 2 bp.
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